HearingTracker
Professional org · Pediatric← The news desk

✦ The Dispatch

Abstracts open for Australasian Early Hearing Detection and Intervention Conference

A dispatch from Hearing Practitioner Australia — filed

Panoramic view of Christchurch city skyline with the Southern Alps snow-capped mountains in the background and a river estuary in the foreground.
✦ PlatePanoramic view of Christchurch city skyline with the Southern Alps snow-capped mountains in the background and a river estuary in the foreground.

submissions are open for the 13th Australasian Early Hearing Detection and Intervention (AEHDI) Conference in Christchurch, New Zealand in May 2027. Organised by the Australasian Newborn Hearing Screening Committee (ANHSC), the conference will be from 10–11 May 2027 at Te Pae Christchurch Convention Centre. Held under the theme “One journey. Many partners....

Continue reading at Hearing Practitioner Australia

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable clinical change — this is a call-for-abstracts announcement for a professional conference in 2027.

✦ Why It Matters ✦

The AEHDI Conference is a key regional forum for advancing newborn hearing screening and early intervention practice across Australasia, and the call for abstracts signals an opportunity for clinicians and researchers to shape the program.

✦ Key Points ✦
  1. 01Abstract submissions are now open for the 13th AEHDI Conference.
  2. 02The conference is scheduled for May 2027 in Christchurch, New Zealand.
  3. 03Focus areas include early hearing detection and intervention for infants and young children.
  4. 04The event draws attendees from across the Australasian region.
✦ Related stories ✦
PU
PubMed·Journal article·Pediatric·

Ototoxicity Associated with Antineoplastic Agents in the Pediatric Population: An Evidence-Based Review of Auditory Monitoring Strategies and Contemporary Diagnostic Frameworks-Narrative Review

Audiologists managing pediatric oncology patients should apply evidence-based auditory monitoring protocols aligned with current diagnostic frameworks for platinum-based chemotherapy ototoxicity; this review consolidates existing guidance but does not introduce new...

PU
PubMed·Journal article·Pediatric·

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network

Audiologists and oncology teams treating pediatric cisplatin patients should be aware of SIOP Ototoxicity Taskforce guidance supporting sodium thiosulfate as an otoprotectant, and advocate for its integration into institutional chemotherapy protocols.